Normal 0 false false false EN-US X-NONE X-NONE/* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"\; mso-tstyle-rowband-size:0\; mso-tstyle-colband-size:0\; mso-style-noshow:yes\; mso-style-priority:99\; mso-style-parent:""\; mso-padding-alt:0in 5.4pt 0in 5.4pt\; mso-para-margin-top:0in\; mso-para-margin-right:0in\; mso-para-margin-bottom:10.0pt\; mso-para-margin-left:0in\; line-height:115%\; mso-pagination:widow-orphan\; font-size:11.0pt\; font-family:"Calibri"\,"sans-serif"\; mso-ascii-font-family:Calibri\; mso-ascii-theme-font:minor-latin\; mso-hansi-font-family:Calibri\; mso-hansi-theme-font:minor-latin\; mso-bidi-font-family:"Times New Roman"\; mso-bidi-theme-font:minor-bidi\;}
\nThe 16th \;International Conference on Clinical &\; Experimental Ophthalmology (CME+CPD accredited)which is going to be held during September 18-20\, 2017 at Zurich\, Switzerland which brings together a unique and international mix of large and medium pharmaceutical\, biotech and diagnostic companies\, leading universities and clinical research institutions making the conference a perfect platform to share experience\, foster \;collaborations \;across industry and academia\, and evaluate emerging technologies across the globe. Ophthalmology 2017 maximizes the opportunity to interact with and learn from your peers from across the country and across the globe it held with the discussions on Retina and Retinal Disorders\, Cornea and External Eye Disease\, Neuro-Ophthalmology\, Glaucoma: Visual Field Loss\, Ocular Microbiology and Immunology\, Novel Approaches to Ophthalmology Therapeutics and many more.
ORGANIZER: METHOD:PUBLISH END:VEVENT END:VCALENDAR